Sweat the small stuff: The human microvasculature and heart disease. Microcirculation 2021 Apr;28(3):e12658
Date
09/18/2020Pubmed ID
32939881Pubmed Central ID
PMC7960576DOI
10.1111/micc.12658Scopus ID
2-s2.0-85091684344 (requires institutional sign-in at Scopus site) 10 CitationsAbstract
Traditionally thought of primarily as the predominant regulator of myocardial perfusion, it is becoming more accepted that the human coronary microvasculature also exerts a more direct influence on the surrounding myocardium. Coronary microvascular dysfunction (CMD) not only precedes large artery atherosclerosis, but is associated with other cardiovascular diseases such as heart failure with preserved ejection fraction and hypertrophic cardiomyopathy. It is also highly predictive of cardiovascular events in patients with or without atherosclerotic cardiovascular disease. This review focuses on this recent paradigm shift and delves into the clinical consequences of CMD. Concepts of how resistance arterioles contribute to disease will be discussed, highlighting how the microvasculature may serve as a potential target for novel therapies and interventions. Finally, both invasive and non-invasive methods with which to assess the coronary microvasculature both for diagnostic and risk stratification purposes will be reviewed.
Author List
Katunaric B, Cohen KE, Beyer AM, Gutterman DD, Freed JKAuthors
Andreas M. Beyer PhD Professor in the Medicine department at Medical College of WisconsinJulie K. Freed PhD, MD Senior Associate Dean, Institute Director, Associate Professor in the Anesthesiology department at Medical College of Wisconsin
David Gutterman MD Emeritus Professor in the Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Coronary CirculationHeart Failure
Humans
Microvessels
Stroke Volume
